FAST-TAVI II 试验:缩短经股动脉 TAVI 术后住院时间
FAST-TAVI II 为前瞻性多中心整群随机对照研究,纳入重度症状性主动脉瓣狭窄并接受经股动脉 TAVI 的患者。干预为实施 10 项质量改进措施的专项培训,主要终点为 3 天内早期出院比例。干预组早期出院比例 58.1% 高于对照组 42.3%,中位住院时间缩短,30 天死亡与再入院无显著差异。
要点
- 专项培训实施 10 项质量措施可提高 TAVI 术后 3 天内早期出院比例
- 干预组中位住院时间较对照组缩短,30 天死亡与心血管再入院无显著增加
- 该干预简单、可快速实施,可用于优化 TAVI 术后住院管理
核心结论
- 该干预简单且可快速实施,能有效且安全地缩短 TAVI 术后住院时间并提高早期出院比例。
研究设计与样本
- FAST-TAVI II 为前瞻性、多中心、整群随机对照研究,纳入重度症状性主动脉瓣狭窄并接受经股动脉 TAVI 的患者。
- 干预组 969 例、对照组 860 例,平均年龄 81.9 ± 6.6 岁,平均 EuroSCORE II 4.4 ± 4.5%。
- 干预为专项培训项目,用于实施 10 项质量改进措施以缩短住院时间,实施期为 8 周。
- 主要终点为 3 天内早期出院比例;次要终点包括住院时间、30 天死亡率和 30 天心血管事件再入院率。
主要发现
- 干预组 563 例(58.1%)实现早期出院,对照组 364 例(42.3%),P < .0001。
- 干预组中位住院时间 3 天(IQR: 3),对照组 4 天(IQR: 3),P < .0001。
- 30 天死亡率两组均低且相近:0.5% vs. 0.9%,P = .30。
- 30 天再入院率两组相近:4.6% vs. 2.8%,P = .28。
关键数值与推荐
- 早期出院定义为 3 天内出院。
- 干预措施为实施 10 项质量改进措施的专项培训,实施期 8 周。
- 主要终点为 3 天内早期出院患者比例。
临床怎么用
- 对经股动脉 TAVI 患者可推行专项培训与 10 项质量改进措施以缩短住院时间。
- 在实施早期出院路径时,30 天死亡与再入院风险未见显著增加。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: The length of stay (LOS) after transcatheter aortic valve implantation (TAVI) remains extremely variable whereas early discharge has been shown to be feasible and safe. The study objective was to evaluate the efficacy and safety of an intervention aimed at reducing LOS after transfemoral TAVI. METHODS: FAST-TAVI II is a prospective, multicentre, cluster, randomized, controlled study including patients with severe symptomatic aortic stenosis, who had transfemoral TAVI. The intervention consisted in a dedicated training programme to implement 10 quality of care measures to reduce LOS with an implementation phase of eight weeks. The primary endpoint was the proportion of patients discharged early within 3 days. Secondary endpoints included: LOS, 30-day mortality and 30-day incidence of readmission for cardiovascular events. RESULTS: During the study period, 969 patients were enrolled in the intervention group and 860 patients in the control group. Mean age was 81.9 ± 6.6 years and mean EuroSCORE II was 4.4 ± 4.5%. Early discharge was achieved in 563 (58.1%) patients in the intervention group vs. 364 (42.3%) patients in the control group (P < .0001). Median LOS was significantly reduced in the intervention group compared to the control group [3 (IQR: 3) vs. 4 days (IQR: 3), P < .0001]. Thirty-day mortality was low and similar in the two groups (0.5% vs. 0.9%, P = .30), as were 30-day readmissions (4.6% vs. 2.8%, P = .28). CONCLUSIONS: The intervention was simple and fast to implement, and was effective and safe to reduce LOS and increase the proportion of patients discharged early after TAVI (NCT04503655).
引用
- Durand E, Beziau-Gasnier D, Michel M, et al. Reducing length of stay after transfemoral transcatheter aortic valve implantation: the FAST-TAVI II trial. Eur Heart J. 2024. PMID: 38437633. doi:10.1093/eurheartj/ehae081
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。